Abdulmonem A Alsaleh

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 20

Top Topics

Prostate Cancer

Trypanosoma Cruzi

Top Venues

Current oncology (Toronto, Ont.)

Pathogens (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Manish Dhawan, Ali A Rabaan, Mahmoud M Al Fawarah, Souad A Almuthree, Roua A Alsubki, Amal H Alfaraj, Mutaib Mosaued Mashraqi, Saleh A Alshamrani, Wesam A Abduljabbar, Ameen S S Alwashmi, Fatimah Al Ibrahim, Abdulmonem A Alsaleh, Faryal Khamis, Jameela Alsalman, Manish Sharma, Talhah Bin Emran
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines 11 (1) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Manish Dhawan, Ali A Rabaan, Mahmoud M Al Fawarah, Souad A Almuthree, Roua A Alsubki, Amal H Alfaraj, Mutaib Mosaued Mashraqi, Saleh A Alshamrani, Wesam A Abduljabbar, Ameen S S Alwashmi, Fatimah Al Ibrahim, Abdulmonem A Alsaleh, Faryal Khamis, Jameela Alsalman, Manish Sharma, Talhah Bin Emran
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines 11 (1) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Manish Dhawan, Ali A Rabaan, Mahmoud M Al Fawarah, Souad A Almuthree, Roua A Alsubki, Amal H Alfaraj, Mutaib Mosaued Mashraqi, Saleh A Alshamrani, Wesam A Abduljabbar, Ameen S S Alwashmi, Fatimah Al Ibrahim, Abdulmonem A Alsaleh, Faryal Khamis, Jameela Alsalman, Manish Sharma, Talhah Bin Emran
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines 11 (1) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Mohd Imran, Mandeep Kumar Arora, Anurag Chaudhary, Shah Alam Khan, Mehnaz Kamal, Manal Mutlaq Alshammari, Raghad Mohammad Alharbi, Nuha Abdullah Althomali, Ibrahim Mohammed Alzimam, Abdullah Ayed Alshammari, Bashair Hamed Alharbi, Amer Mohammad Alshengeti, Abdulmonem A Alsaleh, Shayea A Alqahtani, Ali A Rabaan
MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature. Biomedicines 10 (11) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Ranjan K Mohapatra, Ramadan Abdelmoez Farahat, Manish Dhawan, Sara Alwarthan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Amal H Al-Najjar, Mona A Alhusayyen, Ghadeer Hassan Al-Absi, Yahya Aldawood, Abdulmonem A Alsaleh, Saleh A Alshamrani, Souad A Almuthree, Abdulsalam Alawfi, Amer Mohammad Alshengeti, Ameen S S Alwashmi, Khalid Hajissa, Majed S Nassar
Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. Pathogens (Basel, Switzerland) 12 (1) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Ranjan K Mohapatra, Ramadan Abdelmoez Farahat, Manish Dhawan, Sara Alwarthan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Amal H Al-Najjar, Mona A Alhusayyen, Ghadeer Hassan Al-Absi, Yahya Aldawood, Abdulmonem A Alsaleh, Saleh A Alshamrani, Souad A Almuthree, Abdulsalam Alawfi, Amer Mohammad Alshengeti, Ameen S S Alwashmi, Khalid Hajissa, Majed S Nassar
Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. Pathogens (Basel, Switzerland) 12 (1) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Ranjan K Mohapatra, Ramadan Abdelmoez Farahat, Manish Dhawan, Sara Alwarthan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Amal H Al-Najjar, Mona A Alhusayyen, Ghadeer Hassan Al-Absi, Yahya Aldawood, Abdulmonem A Alsaleh, Saleh A Alshamrani, Souad A Almuthree, Abdulsalam Alawfi, Amer Mohammad Alshengeti, Ameen S S Alwashmi, Khalid Hajissa, Majed S Nassar
Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. Pathogens (Basel, Switzerland) 12 (1) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Ranjan K Mohapatra, Ramadan Abdelmoez Farahat, Manish Dhawan, Sara Alwarthan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Amal H Al-Najjar, Mona A Alhusayyen, Ghadeer Hassan Al-Absi, Yahya Aldawood, Abdulmonem A Alsaleh, Saleh A Alshamrani, Souad A Almuthree, Abdulsalam Alawfi, Amer Mohammad Alshengeti, Ameen S S Alwashmi, Khalid Hajissa, Majed S Nassar
Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. Pathogens (Basel, Switzerland) 12 (1) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Muhammad Muzammal, Alessandro di Cerbo, Eman M Almusalami, Arshad Farid, Muzammil Ahmad Khan, Shakira Ghazanfar, Mohammad Al Mohaini, Abdulkhaliq J Alsalman, Yousef N Alhashem, Maitham A Al Hawaj, Abdulmonem A Alsaleh
In Silico Analysis of the L-2-Hydroxyglutarate Dehydrogenase Gene Mutations and Their Biological Impact on Disease Etiology. Genes 13 (4) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Hajir A Al Saihati, Saad Alhumaid, Roua A Alsubki, Safaa A Turkistani, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Ahlam A Alqatari, Hejji E Alahmed, Dalal A Sharbini, Arwa F Alahmadi, Fatimah Alsalman, Ahmed Alsayyah, Abbas Al Mutair
Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer. Cancers 14 (22) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)